1462P Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination: NEMESIA (non-clear metastatic renal cell carcinoma pembrolizumab axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a)

التفاصيل البيبلوغرافية
العنوان: 1462P Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination: NEMESIA (non-clear metastatic renal cell carcinoma pembrolizumab axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a)
المؤلفون: M. Stellato, S. Buti, M. Maruzzo, M. Bersanelli, P. Ermacora, B.A. Maiorano, V. Prati, U.F.F. De Giorgi, F. Pierantoni, A. Malgeri, A. Mennitto, A. Cavo, M.G. Vitale, M. Santoni, C. Carella, G. Procopio, E. Verzoni, D. Santini
المصدر: Annals of Oncology. 33:S1214-S1215
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Oncology, Hematology
تدمد: 0923-7534
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0016ab9270369c5cadecbdf7f029d286
https://doi.org/10.1016/j.annonc.2022.07.1565
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........0016ab9270369c5cadecbdf7f029d286
قاعدة البيانات: OpenAIRE